Leigh Anne Dageforde, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 22 | 2025 | 2412 | 4.600 |
Why?
|
Tissue and Organ Procurement | 9 | 2024 | 989 | 2.680 |
Why?
|
Carcinoma, Hepatocellular | 9 | 2025 | 2329 | 1.660 |
Why?
|
Waiting Lists | 8 | 2024 | 777 | 1.530 |
Why?
|
Kidney Transplantation | 9 | 2024 | 4270 | 1.340 |
Why?
|
Liver Neoplasms | 9 | 2025 | 4353 | 1.330 |
Why?
|
Organ Transplantation | 4 | 2022 | 1174 | 1.190 |
Why?
|
Living Donors | 5 | 2023 | 645 | 1.030 |
Why?
|
End Stage Liver Disease | 5 | 2024 | 369 | 1.010 |
Why?
|
Health Literacy | 4 | 2015 | 464 | 1.000 |
Why?
|
Hepatitis, Alcoholic | 2 | 2024 | 109 | 0.950 |
Why?
|
Cholangiocarcinoma | 2 | 2020 | 578 | 0.890 |
Why?
|
Tissue Donors | 9 | 2024 | 2395 | 0.860 |
Why?
|
Bezoars | 1 | 2023 | 29 | 0.850 |
Why?
|
Weight Loss | 2 | 2024 | 2710 | 0.810 |
Why?
|
Kidney Failure, Chronic | 6 | 2023 | 2495 | 0.710 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.700 |
Why?
|
Students, Medical | 3 | 2024 | 1959 | 0.660 |
Why?
|
Hepatectomy | 3 | 2025 | 589 | 0.630 |
Why?
|
Patients | 2 | 2015 | 910 | 0.590 |
Why?
|
Motor Vehicles | 1 | 2020 | 280 | 0.580 |
Why?
|
Clinical Clerkship | 1 | 2024 | 568 | 0.570 |
Why?
|
Graft Survival | 8 | 2023 | 3890 | 0.570 |
Why?
|
Renal Dialysis | 4 | 2023 | 1799 | 0.520 |
Why?
|
Motivation | 2 | 2024 | 2018 | 0.510 |
Why?
|
Brachiocephalic Veins | 1 | 2014 | 21 | 0.470 |
Why?
|
Education, Medical, Undergraduate | 1 | 2024 | 1085 | 0.460 |
Why?
|
Fellowships and Scholarships | 1 | 2023 | 1135 | 0.440 |
Why?
|
Absenteeism | 1 | 2015 | 246 | 0.440 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2014 | 208 | 0.430 |
Why?
|
Writing | 1 | 2015 | 199 | 0.420 |
Why?
|
Bile Duct Neoplasms | 1 | 2019 | 626 | 0.420 |
Why?
|
Patient Participation | 1 | 2021 | 1455 | 0.400 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2012 | 50 | 0.390 |
Why?
|
Mesenteric Artery, Superior | 1 | 2012 | 96 | 0.390 |
Why?
|
Women, Working | 1 | 2012 | 85 | 0.390 |
Why?
|
Bile Duct Diseases | 1 | 2012 | 99 | 0.380 |
Why?
|
Career Choice | 2 | 2021 | 769 | 0.380 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2015 | 4058 | 0.370 |
Why?
|
Nephrectomy | 2 | 2018 | 927 | 0.370 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2014 | 290 | 0.360 |
Why?
|
Bile Ducts | 1 | 2012 | 288 | 0.350 |
Why?
|
Brain Death | 2 | 2023 | 360 | 0.350 |
Why?
|
Personnel Selection | 1 | 2012 | 201 | 0.350 |
Why?
|
Aneurysm, False | 1 | 2012 | 264 | 0.330 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 438 | 0.330 |
Why?
|
Thrombosis | 1 | 2023 | 2949 | 0.320 |
Why?
|
Upper Extremity | 1 | 2014 | 682 | 0.320 |
Why?
|
Health Care Costs | 2 | 2012 | 3242 | 0.310 |
Why?
|
Policy | 2 | 2023 | 511 | 0.310 |
Why?
|
Iatrogenic Disease | 1 | 2012 | 553 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2025 | 9373 | 0.300 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3278 | 0.300 |
Why?
|
Specialties, Surgical | 1 | 2012 | 391 | 0.290 |
Why?
|
Models, Economic | 1 | 2012 | 716 | 0.290 |
Why?
|
Registries | 2 | 2024 | 8297 | 0.290 |
Why?
|
Body Mass Index | 2 | 2024 | 13039 | 0.280 |
Why?
|
Catheterization, Central Venous | 1 | 2012 | 539 | 0.270 |
Why?
|
Internship and Residency | 3 | 2023 | 5946 | 0.270 |
Why?
|
Physicians, Women | 1 | 2012 | 512 | 0.260 |
Why?
|
Humans | 53 | 2025 | 765968 | 0.260 |
Why?
|
Physicians | 1 | 2024 | 4588 | 0.250 |
Why?
|
Liver | 4 | 2023 | 7562 | 0.240 |
Why?
|
Retrospective Studies | 18 | 2024 | 81514 | 0.240 |
Why?
|
Adult | 24 | 2025 | 223044 | 0.230 |
Why?
|
Vascular Surgical Procedures | 1 | 2012 | 1485 | 0.220 |
Why?
|
Postoperative Complications | 7 | 2024 | 15747 | 0.220 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2023 | 86 | 0.210 |
Why?
|
Organ Preservation | 2 | 2023 | 399 | 0.200 |
Why?
|
Acute Kidney Injury | 2 | 2024 | 1946 | 0.190 |
Why?
|
Abdominal Muscles | 1 | 2023 | 172 | 0.190 |
Why?
|
Donor Selection | 1 | 2023 | 242 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3230 | 0.180 |
Why?
|
Hepatitis C | 3 | 2020 | 1597 | 0.180 |
Why?
|
Hemostasis | 1 | 2023 | 467 | 0.180 |
Why?
|
Middle Aged | 21 | 2025 | 223009 | 0.170 |
Why?
|
Academies and Institutes | 1 | 2022 | 326 | 0.170 |
Why?
|
Male | 26 | 2025 | 363698 | 0.170 |
Why?
|
Aged | 15 | 2025 | 171117 | 0.170 |
Why?
|
Anastomosis, Surgical | 1 | 2023 | 990 | 0.160 |
Why?
|
Logistic Models | 3 | 2023 | 13266 | 0.160 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2310 | 0.160 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3432 | 0.150 |
Why?
|
Perfusion | 1 | 2023 | 1407 | 0.150 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2018 | 15 | 0.150 |
Why?
|
Female | 25 | 2025 | 396112 | 0.140 |
Why?
|
Exercise | 2 | 2024 | 5937 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6499 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 3 | 2013 | 1737 | 0.140 |
Why?
|
Biliary Tract Diseases | 1 | 2018 | 160 | 0.140 |
Why?
|
Liver Cirrhosis | 2 | 2024 | 1959 | 0.140 |
Why?
|
Abdomen | 1 | 2023 | 1134 | 0.130 |
Why?
|
Survival Rate | 4 | 2024 | 12795 | 0.130 |
Why?
|
Health Expenditures | 2 | 2024 | 2387 | 0.130 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2418 | 0.130 |
Why?
|
Counseling | 1 | 2024 | 1551 | 0.130 |
Why?
|
Educational Status | 1 | 2024 | 2513 | 0.130 |
Why?
|
Resource Allocation | 1 | 2018 | 354 | 0.130 |
Why?
|
Liver Failure | 1 | 2018 | 252 | 0.130 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15880 | 0.120 |
Why?
|
Focus Groups | 1 | 2021 | 1459 | 0.120 |
Why?
|
User-Computer Interface | 1 | 2021 | 1405 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1885 | 0.120 |
Why?
|
Pancreatectomy | 1 | 2019 | 820 | 0.120 |
Why?
|
Tennessee | 1 | 2014 | 123 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3413 | 0.110 |
Why?
|
Program Evaluation | 2 | 2013 | 2499 | 0.110 |
Why?
|
Time Factors | 6 | 2024 | 40065 | 0.110 |
Why?
|
Cost of Illness | 1 | 2024 | 1950 | 0.110 |
Why?
|
Decision Trees | 2 | 2013 | 509 | 0.110 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6832 | 0.110 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2018 | 499 | 0.110 |
Why?
|
Death | 1 | 2018 | 686 | 0.110 |
Why?
|
Prognosis | 5 | 2025 | 29922 | 0.100 |
Why?
|
Obesity | 3 | 2024 | 13076 | 0.100 |
Why?
|
Hepatitis B | 1 | 2018 | 707 | 0.100 |
Why?
|
United States | 8 | 2024 | 72903 | 0.100 |
Why?
|
Quality of Life | 4 | 2024 | 13462 | 0.100 |
Why?
|
Cost-Benefit Analysis | 4 | 2013 | 5526 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12056 | 0.100 |
Why?
|
Peritoneal Dialysis | 1 | 2013 | 161 | 0.100 |
Why?
|
Hypertension | 1 | 2012 | 8626 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1668 | 0.100 |
Why?
|
Decision Support Techniques | 2 | 2012 | 2003 | 0.100 |
Why?
|
Markov Chains | 2 | 2013 | 968 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2022 | 65188 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.090 |
Why?
|
Patient Selection | 1 | 2023 | 4255 | 0.090 |
Why?
|
Models, Econometric | 1 | 2012 | 213 | 0.090 |
Why?
|
Sick Leave | 1 | 2012 | 105 | 0.090 |
Why?
|
Vascular Patency | 1 | 2014 | 912 | 0.090 |
Why?
|
Thigh | 1 | 2012 | 238 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7838 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2020 | 3050 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2018 | 711 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1205 | 0.080 |
Why?
|
Catheterization | 1 | 2013 | 1425 | 0.070 |
Why?
|
Survival Analysis | 2 | 2019 | 10070 | 0.070 |
Why?
|
Treatment Failure | 1 | 2014 | 2652 | 0.070 |
Why?
|
Angiography | 1 | 2012 | 1581 | 0.070 |
Why?
|
Risk Factors | 7 | 2025 | 74840 | 0.070 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1238 | 0.070 |
Why?
|
Workload | 1 | 2012 | 851 | 0.070 |
Why?
|
Cost Savings | 1 | 2012 | 904 | 0.070 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5370 | 0.060 |
Why?
|
Hospital Costs | 1 | 2012 | 956 | 0.060 |
Why?
|
Employment | 1 | 2012 | 1106 | 0.060 |
Why?
|
Child | 4 | 2023 | 80564 | 0.060 |
Why?
|
Preoperative Care | 1 | 2014 | 2267 | 0.060 |
Why?
|
Iron | 1 | 2013 | 1816 | 0.060 |
Why?
|
alpha-Fetoproteins | 1 | 2025 | 226 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3181 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3236 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2334 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39193 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4274 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3141 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9649 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8733 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2039 | 0.050 |
Why?
|
Reoperation | 1 | 2012 | 4294 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5444 | 0.050 |
Why?
|
Life Style | 1 | 2012 | 3926 | 0.040 |
Why?
|
Efficiency | 1 | 2024 | 480 | 0.040 |
Why?
|
Cross Infection | 1 | 2009 | 1427 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12509 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10603 | 0.040 |
Why?
|
Cold Ischemia | 1 | 2018 | 72 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15398 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2013 | 4559 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12976 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20124 | 0.030 |
Why?
|
Peer Group | 1 | 2022 | 701 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13632 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2019 | 512 | 0.030 |
Why?
|
Mentors | 1 | 2021 | 671 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3800 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2018 | 444 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2024 | 2098 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2024 | 2660 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1343 | 0.030 |
Why?
|
Travel | 1 | 2018 | 806 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 24282 | 0.020 |
Why?
|
Equipment Failure | 1 | 2013 | 578 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2025 | 11206 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20659 | 0.020 |
Why?
|
Population Surveillance | 1 | 2018 | 2590 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2009 | 508 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1530 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7066 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 17533 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3853 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2009 | 279 | 0.020 |
Why?
|
Hospitals | 1 | 2018 | 3888 | 0.020 |
Why?
|
Hospitalization | 1 | 2024 | 10808 | 0.010 |
Why?
|
Anemia | 1 | 2013 | 1511 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8067 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5446 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8703 | 0.010 |
Why?
|
Bacteremia | 1 | 2009 | 989 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5508 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6203 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2025 | 59489 | 0.010 |
Why?
|
Critical Illness | 1 | 2009 | 2744 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41649 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 88835 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26318 | 0.010 |
Why?
|
Prospective Studies | 1 | 2009 | 54802 | 0.000 |
Why?
|